Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 30, 2021 - Issue 9
Submit an article Journal homepage
583
Views
9
CrossRef citations to date
0
Altmetric
Drug Evaluation

Sprifermin: a recombinant human fibroblast growth factor 18 for the treatment of knee osteoarthritis

Jia Lia Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China;b Department of Orthopedics, Zhujiang Hospital, Southern Medical University, Guangzhou, ChinaORCID Iconhttps://orcid.org/0000-0003-3572-3690View further author information
ORCID Icon,
Xiaoshuai Wanga Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China;b Department of Orthopedics, Zhujiang Hospital, Southern Medical University, Guangzhou, ChinaORCID Iconhttps://orcid.org/0000-0002-3895-1384View further author information
ORCID Icon,
Guangfeng Ruana Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, ChinaView further author information
,
Zhaohua Zhua Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, ChinaORCID Iconhttps://orcid.org/0000-0003-3913-2564View further author information
ORCID Icon &
Changhai Dinga Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China;c Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia;d Clinical Research Centre, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9479-730XView further author information
ORCID Icon
Pages 923-930 | Received 20 Apr 2021, Accepted 23 Aug 2021, Published online: 03 Sep 2021

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yang Zhao, Qianhua Ou, Yu Cai, Guangfeng Ruan, Yan Zhang & Changhai Ding. (2023) Shedding light on experimental intra-articular drugs for treating knee osteoarthritis. Expert Opinion on Investigational Drugs 32:6, pages 509-524.
Read now

Articles from other publishers (8)

Monica Paesa, Teresa Alejo, Felicito Garcia‐Alvarez, Manuel Arruebo & Gracia Mendoza. (2022) New insights in osteoarthritis diagnosis and treatment: Nano‐strategies for an improved disease management. WIREs Nanomedicine and Nanobiotechnology 15:2.
Crossref
X. Wang, T. Chen, W. Liang, T. Fan, Z. Zhu, P. Cao, G. Ruan, Y. Zhang, S. Chen, Q. Wang, S. Li, Y. Huang, M. Zeng, D.J. Hunter, J. Li & C. Ding. (2022) Synovitis mediates the association between bone marrow lesions and knee pain in osteoarthritis: data from the Foundation for the National Institute of Health (FNIH) Osteoarthritis Biomarkers Consortium. Osteoarthritis and Cartilage 30:9, pages 1270-1277.
Crossref
David M. Ornitz & Nobuyuki Itoh. (2022) New developments in the biology of fibroblast growth factors. WIREs Mechanisms of Disease 14:4.
Crossref
Win Min Oo. (2022) Prospects of Disease-Modifying Osteoarthritis Drugs. Clinics in Geriatric Medicine 38:2, pages 397-432.
Crossref
John Loughlin. (2022) Translating osteoarthritis genetics research: challenging times ahead. Trends in Molecular Medicine 28:3, pages 176-182.
Crossref
Yao Lu, Jieli Chen, Lihua Li, Yumei Cao, Yang Zhao, Xiaoyu Nie & Changhai Ding. (2022) Hierarchical functional nanoparticles boost osteoarthritis therapy by utilizing joint-resident mesenchymal stem cells. Journal of Nanobiotechnology 20:1.
Crossref
Heungdeok Kim, Jinwon Seo, Yunsin Lee, Kiwon Park, Thomas A. Perry, Nigel K. Arden, Ali Mobasheri & Heonsik Choi. (2022) The current state of the osteoarthritis drug development pipeline: a comprehensive narrative review of the present challenges and future opportunities. Therapeutic Advances in Musculoskeletal Disease 14, pages 1759720X2210859.
Crossref
Zongmian Song, Yusheng Li, Chunfeng Shang, Guowei Shang, Hongwei Kou, Jinfeng Li, Songfeng Chen & Hongjian Liu. (2021) Sprifermin: Effects on Cartilage Homeostasis and Therapeutic Prospects in Cartilage-Related Diseases. Frontiers in Cell and Developmental Biology 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.